Document is current
Any future updates will be listed below
-
Authors
Battiston, Kyle
Parrag, Ian
Statham, Matthew
Louka, Dimitra
Fischer, Hans
Mackey, Gillian
Daley, Adam
Gu, Fan
Baldwin, Emily
Yang, Bingqing
Muirhead, Ben
Hicks, Emily Anne
Sheardown, Heather
Kalachev, Leonid
Crean, Christopher http://orcid.org/0000-0001-5251-6998
Edelman, Jeffrey
Santerre, J. Paul
Naimark, Wendy http://orcid.org/0000-0001-9638-005X
- License Information
-
More Information
Article History
Received: 8 October 2020
Accepted: 8 April 2021
First Online: 17 May 2021
Competing interests
: The authors declare the following competing interests: K.B., I.P., M.A.J.S., D.L., G.M., H.F., A.D., E.B., B.Y., J.P.S., and W.N. are employees of Ripple Therapeutics. F.G. is a former employee of Ripple Therapeutics. Ripple Therapeutics has a financial interest in the materials presented in this publication. As employees of Ripple Therapeutics, K.B., I.P., M.A.J.S., D.L., G.M., H.F., A.D., E.B., B.Y., J.P.S., and W.N. have a financial interest in the company in the form of shares and some employees are authors on patents related to the materials in this manuscript (K.B., I.P., M.A.J.S., D.L., H.F., A.D., J.P.S., W.N.). L.K., J.E., and C.C. receive remuneration for consultation from Ripple Therapeutics. The remaining authors declare no competing interests.
